Given the bad performance of the company, reflected in the stock dip that’s been happening for a while, this isn’t a surprise. I hope this is where it will stop, at least for now. I just don’t know how operations will be viable between layoffs in May and this round, and whether we can expect more cuts. Pharma job market is not particularly stellar these days, so I sincerely hope the rest of us get to keep our jobs, for a while at least.
There are no replies in this thread yet. Be the first to post a reply below: